CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Cephalothin Sodium W/ Dextrose In Plastic Container, and what generic alternatives are available?
Cephalothin Sodium W/ Dextrose In Plastic Container is a drug marketed by Baxter Hlthcare and is included in two NDAs.
The generic ingredient in CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER is cephalothin sodium. There are seven drug master file entries for this compound. Additional details are available on the cephalothin sodium profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER?
- What are the global sales for CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER?
- What is Average Wholesale Price for CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER?
Summary for CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Clinical Trials: | 2 |
Patent Applications: | 1,029 |
DailyMed Link: | CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER at DailyMed |
Recent Clinical Trials for CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Instituto Mexicano del Seguro Social | Phase 3 |
Fundação de Amparo à Pesquisa do Estado de São Paulo | Phase 4 |
Federal University of São Paulo | Phase 4 |
See all CEPHALOTHIN SODIUM W/ DEXTROSE IN PLASTIC CONTAINER clinical trials